Skip to main content
logo
Ajooni Biotech Limited (NSE:AJOONI)
India flag India · Delayed Price · Currency is INR
4.000
-0.020 (-0.50%)
Jul 31, 2026, 3:29 PM IST

Ajooni Biotech Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
1,8481,8481,159802.54744.88740.38
Revenue Growth
59.48%59.48%44.38%7.74%0.61%45.06%
Gross Profit
368.68368.68188.4499.0487.45100.24
Operating Income
64.6864.6839.5218.9419.7221.54
Net Income
43.2243.2233.7221.6111.2510.49
Earnings Per Share
0.250.250.200.250.190.21
EPS Growth
27.70%27.70%-20.64%31.16%-9.39%180.50%

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
4.194.1972.74.36.351.75
Total Debt
177.63177.6319.421.6851.7753.51
Net Cash (Debt)
-173.44-173.4453.31-17.37-45.42-51.75
Net Cash Growth
------
Net Cash Per Share
-1.00-1.000.31-0.20-0.76-1.02

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-57.34-57.34-177.37229.1-55.7936.84
Capital Expenditures
-180.28-180.28-20.32-56.02-13.6-21.24
Free Cash Flow
-237.62-237.62-197.69173.09-69.3915.6
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
19.95%19.95%16.26%12.34%11.74%13.54%
Operating Margin
3.50%3.50%3.41%2.36%2.65%2.91%
Pretax Margin
3.11%3.11%3.74%3.73%2.12%1.97%
Profit Margin
2.34%2.34%2.91%2.69%1.51%1.42%
FCF Margin
-12.86%-12.86%-17.06%21.57%-9.32%2.11%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
16.0015.3028.6123.9230.7764.20
P/FCF Ratio
---2.99-43.17
PS Ratio
0.370.360.830.640.470.91